Extended-duration betrixaban versus shorter-duration enoxaparin for venous thromboembolism prophylaxis in critically ill medical patients: an APEX trial substudy

Overview of attention for article published in Intensive Care Medicine, February 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (80th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

news: 1 news outlet

twitter: 3 X users

Citations

dimensions_citation: 19 Dimensions

Readers on

mendeley: 59 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 6,884 followers.

長期間betrixaban投与は短期間エノキサパリン投与と比べて重症患者でのVTEを大出血の増加なしに減少させるかもしれない（非大出血は増加） Extended-duration betrixaban versus shorter-duration enoxaparin for venous thromboembolism prophylaxis in critically ill m.. https://t.co/3s08jv0YJ1

24 Feb 2019

Reply Repost Favourite

RT @lasecip: Extended-duration betrixaban versus shorter-duration enoxaparin for venous thromboembolism prophylaxis in critically ill medic…

19 Feb 2019

Reply Repost Favourite

Extended-duration betrixaban versus shorter-duration enoxaparin for venous thromboembolism prophylaxis in critically ill medical patients: an APEX trial substudy https://t.co/ibd1owXrA4 #IntCareMed

18 Feb 2019

Reply Repost Favourite